A spray vaccine developed from decades of research at Universiti Putra Malaysia could transform how goats and sheep are ...

In life sciences, enterprise value only emerges when generative AI is treated as a business capability and embedded into existing operating models.

US$959.5 million, +61.4% year-on-yearGross profit: US$553.2 million, +103.3% year-on-yearAdjusted net profit: US$230.3 million, +285.0% year-on-yearBusiness Units' PerformanceGenScript Life Science ...

A biotech company which aims to revolutionise drug testing using lab-grown human muscles has secured the backing of a seed-stage investor to accelerate its growth.

Professor Dr SM Abdul Awal of Khulna University has been appointed as the Chief Coordinator for Sustainable Development Goals (SDGs) ...

A deal around a novel drug delivery compound has investors interested. The post This ASX biotech company has piled on more ...

More than 10 pre-profit drug developers are seeking Hong Kong listings as AI-powered biotech platforms draw growing investor interest More than 10 loss-making biotechnology companies have filed for ...

Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company producing precision-engineered ...

Investor attention is also tilting toward strategic minerals, including rare earths, copper and antimony. Read more at ...

Obexelimab marketing applications for the treatment of IgG4-RD expected to be submitted to the FDA in Q2 2026 and the EMA in ...

Scientists make Parkinson’s drug from used plastic bottles - Researchers said the breakthrough could lead to a ‘bio-upcycling industry’ that uses waste materials to make things like flavourings and ...

In addition to OEM distribution, the collaboration provides flexibility for potential future expansion, which could include Dyadic supplying market-ready products for distribution or licensing ...